The regulation of IL-17A and TNF-α engages distinct pathogenetic mechanisms, with IL-17A/IL-23 as the primary pathogenetic axis in psoriasis, while TNF-α assumes a supportive role (49, 50). The gene discussed is IL23A; the disease is psoriasis.